A single hedge fund has placed a bigger bet on Elon Musk’s private rocket company than nearly anyone on Wall Street, and it could net them over $10 billion.
Darsana Capital Partners has invested nearly 60% of its capital in Space Exploration Technologies Corp., a highly concentrated bet that stands to make the firm over $10 billion ahead of the rocket-maker’s widely anticipated initial public offering. The move represents an extraordinary level of conviction from the hedge fund, placing a massive portion of its portfolio into a single, illiquid private asset.
While Darsana has not commented publicly on the position, the sheer scale of the investment speaks for itself. "For a fund to allocate over half its capital to a single private name is an extraordinary display of conviction," said Jordan Fitzgerald, a capital markets analyst at Bloomberg, in a May 18 report. "It's a bet not just on the company, but on a successful, near-term public offering."
The massive position in SpaceX contrasts sharply with the de-risking strategies many investors are currently employing. As the AI-fueled tech rally pushes indexes to new records, some market participants have been rotating into defensive ETFs like the Consumer Staples Select Sector SPDR Fund (XLP) as a hedge. During the tech selloff from November 2021 to December 2022, the tech-heavy Invesco QQQ Trust fell 31% while XLP gained 8%, according to 24/7 Wall St.
Darsana’s move is the antithesis of this approach. It is a pure-play offensive bet on the future of aerospace and the growth of the "Muskonomy," doubling down on specific-company risk when others are broadly hedging. The stake is significant not just for its size, but for its timing. With a SpaceX IPO expected to be one of the largest market debuts in history, Darsana's position, acquired on private secondary markets, would convert into highly liquid public shares, likely unlocking a 10-figure profit and validating its high-stakes strategy.
The Anti-Hedge
In a market wrestling with bubble concerns in artificial intelligence, many investors are seeking shelter in non-correlated assets. The Consumer Staples Select Sector SPDR Fund (XLP), which holds companies like Walmart and Coca-Cola, is a classic defensive choice. Its resilience during past tech downturns makes it a popular portfolio hedge for those with heavy exposure to names like Nvidia. An investor holding XLP and a tech-heavy fund in 2022 would have significantly cushioned their losses.
Darsana’s strategy rejects this defensive posture entirely. Instead of buying the corporate equivalent of toothpaste and soda, the fund has allocated the majority of its capital to a high-growth, high-risk venture defined by rocket launches and satellite constellations. This demonstrates a belief that the potential reward in SpaceX outweighs the systemic risks that have other managers seeking safety. It is a high-conviction trade that suggests the firm sees more upside in a single innovative company than in the entire consumer staples sector.
A Bet on the ‘Muskonomy’
For years, the only way for public investors to bet on Elon Musk’s vision was through Tesla Inc. The upcoming SpaceX IPO is set to change that, creating a second major entry point into the "Muskonomy." As noted by Bloomberg, this could potentially divert capital and attention away from the electric-vehicle maker and toward Musk's new public entity.
Darsana Capital’s investment is the ultimate institutional validation of this shift. By taking such a large, pre-IPO stake, the fund is positioning itself to be one of the biggest beneficiaries of the public market’s initial rush into SpaceX. This single bet highlights the immense private-market demand for SpaceX shares and the extreme conviction some institutional investors have in its long-term narrative, separate from Tesla. The move effectively front-runs the massive retail and institutional demand expected to materialize once SpaceX finally lists, setting the stage for what could be one of the most profitable single trades of the decade.
This article is for informational purposes only and does not constitute investment advice.